Summary
Andrew Giessel is a data scientist and computational biologist turned technology leader with a Ph.D. in Neuroscience and 14 years of experience building AI and data platforms for R&D. As co-founder and CTO of Growth Signals and former executive director of AI engineering at Moderna, he has led teams that translate cutting-edge algorithms into production systems, including launching Moderna’s internal generative AI platform, mChat. He blends deep domain knowledge in biology and microscopy with hands-on software expertise across Python, PyTorch, Docker, Spark and extensive Linux operations. His background includes building custom instrumentation and open-source analysis tools for two-photon imaging, reflecting a practical experimentalist’s approach to software and hardware integration. Comfortable across languages from C++ to JavaScript and databases from SQL to MongoDB, he specializes in turning noisy scientific data into robust, scalable ML products. Based in Somerville, MA, he thrives at the intersection of algorithmic innovation and the science it enables, with a track record of shipping impactful systems inside fast-moving biotech environments.
14 years of coding experience
10 years of employment as a software developer
University of Kansas
Doctor of Philosophy (PhD) Neuroscience, Doctor of Philosophy (PhD) Neuroscience at Harvard Medical School